Armistice Capital »

Reviva Pharmaceu shares owned by Armistice Capital

Quarter-by-quarter ownership of Reviva Pharmaceu (RVPH) shares owned by Armistice Capital from 13F filings

Historical chart of Armistice Capital investment in Reviva Pharmaceu

Tip: Access up to 7 years of quarterly data

All positions including Reviva Pharmaceu held by Armistice Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Reviva Pharmaceu by Armistice Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $432k 592k 0.73

More positions owned by Armistice Capital

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Ptc Therapeutics I (PTCT)
Travere Therapeutics (TVTX)
Madrigal Pharmaceuticals (MDGL)
Immunovant (IMVT)
Supernus Pharmaceuticals (SUPN)
Neurocrine Biosciences (NBIX)
Freshpet (FRPT)
Incyte Corporation (INCY)
Dyne Therapeutics (DYN)
Amazon (AMZN)
Ironwood Pharmaceuticals Com Cl A (IRWD)

View all positions for Armistice Capital

Top funds holding Reviva Pharmaceu

Millennium Management
Jpmorgan Chase & Co
Armistice Capital
GSA Capital Partners
EMC Capital Management
Vanguard Capital Management
Warberg Asset Management
Geode Capital Management
Vanguard Fiduciary Trust
BlackRock
Hrt Financial
Castleview Partners
Two Sigma Investments
Morgan Stanley
UBS Group

View all funds holding Reviva Pharmaceu